Clinical Trial Update: A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of a pramlintide and metreleptin combination in obese subjects; the trial was terminated and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Pramlintide + metreleptin (pramlintide + metreleptin)

Snippet

Sponsor: AstraZeneca | Conditions: Obesity | Phase 2 | Status: TERMINATED | Results posted: 2013-12-09